Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
2020 · International Journal of Infectious Diseases · 565 citations
https://doi.org/10.1016/j.ijid.2020.06.099
G
Gina Maki
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
1.1K
Citations
8
h-index
8
i10-index
Gina Maki is an academic researcher from Henry Ford Health System. The author has contributed to research in topics: Antibiotic Use and Resistance & Antibiotic Resistance in Bacteria & Nosocomial Infections in ICU. The author has an h-index of 8, co-authored 31 publications.
ORCID: 0000-0002-3479-4895Papers by this author
worksAntibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
2021 · International Journal of Infectious Diseases · 248 citations
https://doi.org/10.1016/j.ijid.2020.12.087
Author response to letter from Gomez et al.
2019 · International Journal of Infectious Diseases · 1 citations
https://doi.org/10.1016/j.ijid.2019.11.030
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat